image
Healthcare - Biotechnology - NASDAQ - US
$ 2.53
-1.17 %
$ 73 M
Market Cap
-0.81
P/E
BALANCE SHEET
127 M ASSETS
-5.83%
18 M LIABILITIES
109.89%
109 M EQUITY
-13.64%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Aerovate Therapeutics, Inc.
image
Current Assets 124 M
Cash & Short-Term Investments 122 M
Receivables 0
Other Current Assets 1.79 M
Non-Current Assets 3.19 M
Long-Term Investments 0
PP&E 902 K
Other Non-Current Assets 2.28 M
Current Liabilities 17.6 M
Accounts Payable 2.4 M
Short-Term Debt 840 K
Other Current Liabilities 14.4 M
Non-Current Liabilities 325 K
Long-Term Debt 255 K
Other Non-Current Liabilities 70 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 23.5 22.4 54.2 4.6 3.5
Short Term Investments 98.9 106.8 113.2 0 0
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 1.8 2.3 7.0 0.1 0
Total Current Assets 124.2 131.5 174.3 4.7 3.5
PP&E 0.9 1.2 0.7 39 K 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0 0 0
Other Long Term Assets 2.3 2.6 0.3 0 0
Other Assets 0 0 0 0 0
Total Assets 127.4 135.3 175.4 4.7 3.5
LIABILITIES
Accounts Payable 2.4 2.6 1.2 0.6 0.5
Short Term Debt 0.8 0.8 0.4 0 0
Other Current Liabilities 14.4 4.4 1.0 1.2 0.1
Total Current Liabilities 17.6 7.8 2.5 1.8 0.7
Long Term Debt 0.3 0.7 0.4 0 2.5
Deferred Tax Income 0 0 0 0 0
Other Liabilities 70 K 71 K 13 K 0 4.0
Total Liabilities 18.0 8.6 2.9 18.1 7.2
EQUITY
Common Stock 3 K 2 K 2 K 0 0
Retained Earnings (163.4) (87.9) (36.4) (13.4) (3.6)
Other Accumulative Comprehensive Income/Loss 0.2 (0.5) 59 K 0 0
Total Equity 109.5 126.7 172.4 (13.3) (3.6)
Total Liabilities and Equity 127.4 135.3 175.4 4.7 3.5
SHARES OUTSTANDING
Common Shares Outstanding 26.3 24.5 24.4 24.4 24.4